This is Martin Birchier's Typepad Profile.
Join Typepad and start following Martin Birchier's activity
Join Now!
Already a member? Sign In
Martin Birchier
Recent Activity
While Pfizer's recent disclosures indicate a pervasive difficulty to bring promising Phase 3 drugs to market, its abilities outside the drug market should not be discounted. Pfizer has made some pretty good strides in the medical device field (stents and artificial joints, for example). Pfizer's 2012 decision to focus was not limited to drug R&D. I wonder whether it might not turn to medical devices to prop itself up in Q1 and Q2 this year.
Martin Birchier is now following The Typepad Team
Jan 29, 2014